Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella,
Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella, group vice presidentof Siemens' nuclear medicine unit in Hoffman Estates, IL.
Siemens acquired marketing rights to CTI's PET scanner and RadioisotopeDelivery System (RDS) cyclotron through an investment and marketingagreement in 1987 (SCAN 11/25/87). Siemens will continue to handlesales and support of the ECAT PET line and will arrange for CTIsupport of cyclotron service contracts currently in place.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.